Events & Presentations
NurOwn Program Update Call Regarding Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
Teleconference Replay Number: 1-888-254-7270
Tools
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds